Fact CheckerSign in

NCT05278416Completed

Regular Home Use of Dual-light Photodynamic Therapy in the Management of Chronic Periodontitis

Regular Home Use of Dual-light Photodynamic Therapy in the Management of Chronic Periodontitis.

Source: ClinicalTrials.gov · Last updated 22 Jan 2026

Brief summary (registry, in English)

The study is a single site, randomized clinical trial designed to determine the efficacy of the Lumoral treatment in periodontitis patients.

Status (registry)
Completed
Study type
Interventional
Enrollment
202 (actual)
First submitted
7 Feb 2022
Start date
8 Feb 2022
Primary completion date
14 Apr 2025
Lead sponsor
Koite Health Oy
NCT number
NCT05278416

What you commit to

  • Study type: Interventional
  • Participants enrolled: 202
  • From 8 Feb 2022 to the primary completion date, 14 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Periodontal treatment during the previous 3 months

Other illness

  • Any systemic disease (e.g., wound healing dysfunctions) that could alter the progression of periodontal disease
  • Allergic to the photosensitizer

Lab values

  • Untreated/uncontrollable diabetes mellitus (DM) with HbA1c \>7%, and HbA1c \> 8 if insulin treated DM
  • Use of medicine that would affect the periodontal tissue within the last 6 months (antibiotics, anti-inflammatories, anticonvulsants, immunosuppressants, or calcium channel blockers, including doxycycline, bisphosphonates and chlorhexidine)

Other

  • Presence of major physical limitation or restriction that prohibit the hygiene procedures used in the study protocol
  • Removable major prosthesis or major orthodontic appliance
  • Active smoking, or habitual use of smokeless tobacco products
  • Pregnancy or lactation
  • A need for a hopeless teeth extraction, or open cavities in need for immediate endodontic treatment

Who the study is looking for

  • Periodontal disease stage I-III, according to criteria the American Academy of Periodontology (AAP) with at least 2 mm interdental CAL in the site of greatest loss
  • Age of 18-85 years
  • Presence of \> 20 teeth
  • Agreement to participate in the study and to sign a written consent form

Age in the registry: 18 years to 85 years · Sex: All · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Metropolia University of applied sciences
Coordinator of this site? Confirm its status
HelsinkiFinlandUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.